Sign in

CIK 0001175680

  • Non-accelerated filer
  • Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
Operating
EIN
753056237
Phone
+1 360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
  1. 4 Grant or award CMO acquired 6,950 shares (grant or award)
  2. 4 Grant or award CFO acquired 5,208 shares (grant or award)
  3. 4 Grant or award Chief Technology Officer acquired 7,102 shares (grant or award)
  4. 4 Grant or award CFO & Interim President acquired 5,614 shares (grant or award)
  5. 4 Grant or award CMO acquired 7,492 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Grant or award Chief Technology Officer acquired 12,428 shares (grant or award)
  8. 4 Grant or award CFO & Interim President acquired 9,824 shares (grant or award)
  9. 4 Grant or award CMO acquired 13,112 shares (grant or award)
  10. 4 Grant or award Chief Technology Officer acquired 13,020 shares (grant or award)
  11. 4 Grant or award CFO & Interim President acquired 10,292 shares (grant or award)
  12. 4 Grant or award CMO acquired 13,736 shares (grant or award)
  13. 4 Grant or award Chief Technology Officer acquired 13,671 shares (grant or award)
  14. 4 Grant or award CFO & Interim President acquired 10,807 shares (grant or award)
  15. 4 Grant or award CMO acquired 14,423 shares (grant or award)
  16. 4 Grant or award CMO acquired 89,985 shares (grant or award)
  17. 4 Grant or award Chief Technology Officer acquired 85,296 shares (grant or award)
  18. 4 Grant or award Recknor Chris P acquired 30,696 shares (grant or award)
  19. 4 Grant or award CFO & Interim President acquired 67,425 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 4 of 22 · 435 filings